Penumbra, Inc Most Important Performance Measures
The measures each proxy statement lists as most important for linking pay to performance (Item 402(v) tabular list), as tagged, newest proxy first.
- 2024-04-24: Measure Revenue.
- 2024-04-24: Measure Non-GAAP income from operations.
- 2025-04-16: Measure Revenue.
- 2025-04-16: Measure Non-GAAP income from operations (including non-GAAP operating margin).
| Proxy filed | Measure |
|---|---|
| 2024-04-24 | Revenue |
| 2024-04-24 | Non-GAAP income from operations |
| 2025-04-16 | Revenue |
| 2025-04-16 | Non-GAAP income from operations (including non-GAAP operating margin) |
| 2026-04-29 | Revenue |
| 2026-04-29 | Non-GAAP income from operations (including non-GAAP operating margin)• |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |